Guideline on the clinical investigation of Plasma derived Fibrin Sealant/Haemostatic Products

Name: Guideline on the clinical investigation of Plasma derived Fibrin Sealant/Haemostatic Products
Creator: Therapeutic Goods Administration
Keywords: australia,clinical-investigation,guidelines,investigation,scientific

Information

Original link

Type

International scientific guidelines adopted in Australia

Regulated products

Medical Devices

Topics

Biological Medicines, Listed Medicines, Prescription Medicines

Published

July 18, 2024

Last updated

July 18, 2024

Description

We have adopted this International Scientific Guideline - CPMP/BPWG/1089/00

Organization

Therapeutic Goods Administration (TGA) 🇦🇺

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

2 Main files

Guideline_on_the_clinical_investigation_of_plasma_derived_fibrin_sealant_haemostatic_products

Updated on July 18, 2024

pdf

URL: https://www.tga.gov.au/sites/default/files/2024-07/guideline_on_the_clinical_investigation_of_plasma_derived_fibrin_sealant_haemostatic_products.pdf
Permalink: https://data.openrid.co/en/datasets/r/549c41d7-e1ec-4daa-b009-1de07fb32e9e
MIME Type: application/pdf

Created on: July 18, 2024
Modified on: July 18, 2024

Guideline on the clinical investigation of Plasma derived Fibrin Sealant/Haemostatic Products

Updated on July 18, 2024

html

URL: https://www.tga.gov.au/resources/resource/international-scientific-guidelines/guideline-clinical-investigation-plasma-derived-fibrin-sealanthaemostatic-products
Permalink: https://data.openrid.co/en/datasets/r/1ed61c21-cc4d-4151-afab-12b35507bc0f
MIME Type: text/html

Created on: July 18, 2024
Modified on: July 18, 2024

Guideline on the clinical investigation of Plasma derived Fibrin Sealant/Haemostatic Products

Information

Type

Regulated products

Topics

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed